Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice (Q42006157)
Jump to navigation
Jump to search
scientific article published on 26 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice |
scientific article published on 26 October 2014 |
Statements
1 reference
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice (English)
1 reference
Bowen Lin
1 reference
Nobutaka Koibuchi
1 reference
Yu Hasegawa
1 reference
Daisuke Sueta
1 reference
Kensuke Toyama
1 reference
Ken Uekawa
1 reference
MingJie Ma
1 reference
Takashi Nakagawa
1 reference
Hiroaki Kusaka
1 reference
Shokei Kim-Mitsuyama
1 reference
26 October 2014
1 reference
1 reference
148
1 reference
26 October 2014
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference